[EN] HYDROXYALKYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE L'HYDROXYALKYL PIPÉRAZINE UTILISÉS COMME MODULATEURS DU RÉCEPTEUR CXCR3
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2016113344A1
公开(公告)日:2016-07-21
The invention relates to compounds of Formula (I) wherein n, X, R1 and R2 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.